PT101896A - MATERIAL BIOLóGICO MODIFICADO, NOMEADAMENTE UM ANIMAL TRANSGéNICO, E MéTODO DE TRANSPLANTE, DE TECIDO ANIMAL - Google Patents

MATERIAL BIOLóGICO MODIFICADO, NOMEADAMENTE UM ANIMAL TRANSGéNICO, E MéTODO DE TRANSPLANTE, DE TECIDO ANIMAL

Info

Publication number
PT101896A
PT101896A PT101896A PT10189696A PT101896A PT 101896 A PT101896 A PT 101896A PT 101896 A PT101896 A PT 101896A PT 10189696 A PT10189696 A PT 10189696A PT 101896 A PT101896 A PT 101896A
Authority
PT
Portugal
Prior art keywords
species
animal
addition
rejection
biological material
Prior art date
Application number
PT101896A
Other languages
English (en)
Other versions
PT101896B (pt
Inventor
David James Graham White
Alan Frederick Williams
Original Assignee
Imutran Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26296038&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT101896(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB898922987A external-priority patent/GB8922987D0/en
Priority claimed from GB909017198A external-priority patent/GB9017198D0/en
Application filed by Imutran Ltd filed Critical Imutran Ltd
Publication of PT101896A publication Critical patent/PT101896A/pt
Publication of PT101896B publication Critical patent/PT101896B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/108—Swine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/02—Animal zootechnically ameliorated
    • A01K2267/025—Animal producing cells or organs for transplantation
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Environmental Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Animal Husbandry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT101896A 1989-10-12 1996-07-15 MATERIAL BIOLóGICO MODIFICADO, NOMEADAMENTE UM ANIMAL TRANSGéNICO, E MéTODO DE TRANSPLANTE, DE TECIDO ANIMAL PT101896B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898922987A GB8922987D0 (en) 1989-10-12 1989-10-12 Modified biological material
GB909017198A GB9017198D0 (en) 1990-08-06 1990-08-06 Modified biological material

Publications (2)

Publication Number Publication Date
PT101896A true PT101896A (pt) 1998-02-27
PT101896B PT101896B (pt) 2003-01-31

Family

ID=26296038

Family Applications (2)

Application Number Title Priority Date Filing Date
PT95580A PT95580B (pt) 1989-10-12 1990-10-12 Processo para a preparacao de material biologico modificado
PT101896A PT101896B (pt) 1989-10-12 1996-07-15 MATERIAL BIOLóGICO MODIFICADO, NOMEADAMENTE UM ANIMAL TRANSGéNICO, E MéTODO DE TRANSPLANTE, DE TECIDO ANIMAL

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PT95580A PT95580B (pt) 1989-10-12 1990-10-12 Processo para a preparacao de material biologico modificado

Country Status (27)

Country Link
US (1) US6495735B1 (pt)
EP (2) EP0709459A3 (pt)
JP (1) JP3302358B2 (pt)
KR (2) KR100317106B1 (pt)
CN (2) CN1122719C (pt)
AT (1) ATE139562T1 (pt)
AU (1) AU654116B2 (pt)
BG (1) BG61080B1 (pt)
CA (1) CA2067235A1 (pt)
CY (1) CY1996A (pt)
DE (2) DE495852T1 (pt)
DK (1) DK0495852T3 (pt)
ES (1) ES2060561T3 (pt)
FI (1) FI921618A0 (pt)
GR (2) GR940300004T1 (pt)
HK (1) HK48497A (pt)
HU (1) HUT64584A (pt)
IE (1) IE75345B1 (pt)
IL (2) IL95970A0 (pt)
IN (1) IN171948B (pt)
MY (1) MY107433A (pt)
NO (2) NO303502B1 (pt)
NZ (2) NZ235657A (pt)
PT (2) PT95580B (pt)
RO (1) RO109863B1 (pt)
SG (1) SG72614A1 (pt)
WO (1) WO1991005855A1 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5705732A (en) * 1989-06-12 1998-01-06 Oklahoma Medical Research Foundation Universal donor cells
EP0483247A4 (en) * 1989-07-21 1992-12-09 Washington University Recombinantly produced human membrane cofactor protein (mcp)
CA2082277A1 (en) * 1990-05-11 1991-11-12 Damien F. J. Purcell Cd46 variants
US5846715A (en) * 1990-05-11 1998-12-08 The Austin Research Institute CD46 variants
WO1993002188A1 (en) * 1991-07-15 1993-02-04 Oklahoma Medical Research Foundation Universal donor cells
US6916654B1 (en) * 1992-06-29 2005-07-12 Oklahoma Medical Research Foundation Universal donor cells
CA2144767A1 (en) * 1992-09-22 1994-03-31 Guerard W. Byrne Delivery of proteins by intermembrane transfer for preaccommodation of xenogeneic organ transplants and other purposes
US5627264A (en) * 1994-03-03 1997-05-06 Alexion Pharmaceuticals, Inc. Chimeric complement inhibitor proteins
CA2196311A1 (en) * 1994-08-19 1996-02-29 David H. Sachs Genetically engineered swine cells
US6030833A (en) * 1995-08-04 2000-02-29 The General Hospital Transgenic swine and swine cells having human HLA genes
US6166288A (en) * 1995-09-27 2000-12-26 Nextran Inc. Method of producing transgenic animals for xenotransplantation expressing both an enzyme masking or reducing the level of the gal epitope and a complement inhibitor
AU1933897A (en) * 1996-03-22 1997-10-17 Imutran Limited Surfaces which prevent or reduce complement activation
WO1998042850A1 (en) 1997-03-26 1998-10-01 Rpms Technology Limited Anticoagulant fusion protein anchored to cell membrane
WO1999003336A1 (fr) 1997-07-14 1999-01-28 Nippon Meat Packers, Inc. Mammiferes transgeniques
US7419683B2 (en) * 1997-10-31 2008-09-02 United States Of America As Represented By The Secretary Of The Army Method of inhibiting side effects of pharmaceutical compositions containing amphiphilic vehicles or drug carrier molecules
SE523817C2 (sv) 1999-02-05 2004-05-18 Corline Systems Ab Användning av ett koagulationsförebyggande ämne i samband med transplantation av insulinproducerande celler
GB9905503D0 (en) 1999-03-10 1999-05-05 Adprotech Plc Novel compound formulations and methods of delivery
WO2005009134A1 (en) * 2003-07-21 2005-02-03 Lifecell Corporation ACELLULAR TISSUE MATRICES MADE FROM GALACTOSE α-1,3-GALACTOSE-DEFICIENT TISSUE
CN103891675B (zh) 2009-08-14 2016-12-07 雷维维科公司 用于糖尿病治疗的多转基因猪
US9420770B2 (en) 2009-12-01 2016-08-23 Indiana University Research & Technology Corporation Methods of modulating thrombocytopenia and modified transgenic pigs
BR112013005116A2 (pt) 2010-09-03 2019-09-24 Stem Centrx Inc moduladores e métodos de uso
NZ759163A (en) 2011-02-14 2023-03-31 Revivicor Inc Genetically modified pigs for xenotransplantation of vascularized xenografts and derivatives thereof
EP3799893A1 (en) 2013-11-04 2021-04-07 LifeCell Corporation Methods of removing alpha-galactose
CN114686427B (zh) * 2022-05-23 2022-07-29 中国人民解放军总医院第一医学中心 一种脾脏调节型b淋巴细胞及其制备方法与应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1982004443A1 (en) * 1981-06-12 1982-12-23 Ohio Univ Genetic transformation of zygotes
US4431636A (en) 1982-05-24 1984-02-14 American Cyanamid Company Bis(4-O-polyhexaose-thio)-phenyl ureas and method of use
US5109113A (en) * 1986-05-02 1992-04-28 Genentech, Inc. Membrane anchor fusion polypeptides
JPS62104594A (ja) * 1985-10-31 1987-05-15 Terumo Corp クエン酸塩利用能検査用培地組成物
JPH0742235B2 (ja) * 1985-11-08 1995-05-10 三共株式会社 自己免疫性疾病の予防・治療剤
IL82390A0 (en) * 1986-05-02 1987-10-30 Genentech Inc Nucleic acid and methods for the synthesis of novel daf compositions
GB8615942D0 (en) * 1986-06-30 1986-08-06 Animal & Food Research Council Peptide production
IL89790A (en) * 1988-04-01 2002-05-23 Johns Hopking University Sequences of nucleic acids encoding and cells producing CR1 protein and methods for its production and purification
DE3830271A1 (de) 1988-09-06 1990-03-15 Goetze Otto Mittel mit immunsuppressiver wirkung
US5573940A (en) * 1989-06-12 1996-11-12 Oklahoma Medical Research Foundation Cells expressing high levels of CD59

Also Published As

Publication number Publication date
SG72614A1 (en) 2000-05-23
BG96329A (bg) 1993-12-24
GR3020741T3 (en) 1996-11-30
NO303502B1 (no) 1998-07-20
PT101896B (pt) 2003-01-31
CN1122719C (zh) 2003-10-01
GR940300004T1 (en) 1994-02-28
IN171948B (pt) 1993-02-13
PT95580B (pt) 1999-05-31
NO982131L (no) 1992-04-10
RO109863B1 (ro) 1995-06-30
EP0495852B1 (en) 1996-06-19
IL95970A0 (en) 1992-05-25
CY1996A (en) 1997-09-05
FI921618A (fi) 1992-04-10
WO1991005855A1 (en) 1991-05-02
CA2067235A1 (en) 1991-04-13
CN1491624A (zh) 2004-04-28
HK48497A (en) 1997-04-25
HU9201240D0 (en) 1992-06-29
EP0709459A2 (en) 1996-05-01
MY107433A (en) 1995-12-30
ES2060561T3 (es) 1996-08-01
BG61080B1 (bg) 1996-10-31
NZ248153A (en) 1997-07-27
EP0495852A1 (en) 1992-07-29
ES2060561T1 (es) 1994-12-01
DE69027535D1 (de) 1996-07-25
NO921438D0 (no) 1992-04-10
DE495852T1 (de) 1994-03-31
JPH05503074A (ja) 1993-05-27
NO921438L (no) 1992-04-10
US6495735B1 (en) 2002-12-17
FI921618A0 (fi) 1992-04-10
NZ235657A (en) 1994-05-26
ATE139562T1 (de) 1996-07-15
DE69027535T2 (de) 1996-11-28
JP3302358B2 (ja) 2002-07-15
CN1051199A (zh) 1991-05-08
IE75345B1 (en) 1997-08-27
KR100317106B1 (ko) 2001-12-22
HUT64584A (en) 1994-01-28
NO982131D0 (no) 1998-05-11
AU654116B2 (en) 1994-10-27
KR920702410A (ko) 1992-09-04
AU6539290A (en) 1991-05-16
EP0709459A3 (en) 1999-01-07
IE903649A1 (en) 1991-04-24
DK0495852T3 (da) 1996-07-15
PT95580A (pt) 1991-09-13
IL120795A0 (en) 1997-09-30

Similar Documents

Publication Publication Date Title
PT101896A (pt) MATERIAL BIOLóGICO MODIFICADO, NOMEADAMENTE UM ANIMAL TRANSGéNICO, E MéTODO DE TRANSPLANTE, DE TECIDO ANIMAL
DE60030770D1 (de) Verwendung von taurolidin oder taurultam zur herstellung eines medikaments zur behandlung von ovarialkarzinomen
ES2057027T3 (es) Un procedimiento para preparar un compuesto macrolido.
MXPA98002434A (es) Animales transgenicos para xenotrasplante con rechazo reducido de anticuerpos mediados.
DE3855220D1 (de) Methode zur beseitigung von infektionserregern in geweben
TR200002259T2 (tr) Esnetilerek kristalize edilebilir elastomerlerden tıbbi implantlar ve implantasyon metotları.
DE69325948D1 (de) Entfernung von Antikörpern aus von Blut stammenden Zusammensetzungen unter Erhalt von Gerinnungsfaktoren
DK0410319T3 (da) Middel til spirogyrabekæmpelse og desodorisering
DK405983D0 (da) Biologiske ukrudtsbekaempelsesmidler
DE69034147D1 (de) Verfahren zur Desinfektion von Knochengeweben
DE59308555D1 (de) Vorrichtung für eine Entalkoholisierungsanlage
ES2115527B1 (es) Sistema para la propagacion de plantas por estolones y elementos utilizables en dicho sistema.
DK67282A (da) Middel til afloevning af kulturplanter
ATE255908T1 (de) Immunotoxinmischungen zur behandlung von immunkrankheiten.
ES2087885T3 (es) Soporte de desodorante, particularmente para tazas de wc.
TR26704A (tr) Muamele edilmis kullanim disi tohumun kullanilir hale getirilmesi.
CA2254889A1 (en) A promoter gene for a porcine complement inhibitor
JPS5296732A (en) Microbial insecticide for extermination of white flies
ATE8096T1 (de) Sulfonamide, sie enthaltende zusammensetzungen und verfahren zur regulierung des wachstums unerwuenschter vegetation.

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19961112

FG3A Patent granted, date of granting

Effective date: 20021203

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20070115